Evidence map›Paper›PMID 21481789›Full record

ArticleCancer cell2011

Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene.

Douglas B Stairs, Lauren J Bayne, Ben Rhoades, Maria E Vega, Todd J Waldron, Jiri Kalabis, Andres Klein-Szanto, Ju-Seog Lee, Jonathan P Katz, J Alan Diehl and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer cell, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 133 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
133citing papers in PubMed, 1 pooled it
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

133 citing papers in PubMed, 1 synthesis or guideline pooled it, 188 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Esophageal cancer: from pathogenesis to precision therapies.Signal transduction and targeted therapy · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Functional analysis ofbioRxiv : the preprint server for biology · 2024
    Article
  12. Article
  13. Cellular Origins and Lineage Plasticity in Cancer.Cold Spring Harbor perspectives in medicine · 2024
    Review
  14. Article
  15. Functions of p120-catenin in physiology and diseases.Frontiers in molecular biosciences · 2024
    Review
  16. Article
  17. Article
  18. Esophageal organoids: applications and future prospects.Journal of molecular medicine (Berlin, Germany) · 2023
    Review
  19. Article
  20. Article

73 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Douglas B StairsDivision of Gastroenterology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Lauren J Bayne
Ben Rhoades
Maria E Vega
Todd J Waldron
Jiri Kalabis
Andres Klein-Szanto
Ju-Seog Lee
Jonathan P Katz
J Alan Diehl
Albert B Reynolds
Robert H Vonderheide
Anil K Rustgi
University of Pennsylvania · USCancer Research Institute · USFox Chase Cancer Center · USPenn State Milton S. Hershey Medical Center · USThe University of Texas MD Anderson Cancer Center · USUPMC Hillman Cancer Center · USVanderbilt University · US

Funding

UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SHELLEY L BERGER · 1985 to 2026
$222.3M
Understanding and Controlling p120 Dysfunction in CRCP50CA095103 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI COFFEY, ROBERT J. · 2002 to 2017
$33.6M
TRANSGENIC AND CHIMERIC MOUSE COREP30DK050306 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Ken Hashigiwa Cadwell · 1997 to 2026
$32.5M
Transformed Esophageal Epithelial Cells and the Tumor MicroenvironmentP01CA098101 · NCI · UNIVERSITY OF PENNSYLVANIA · PI RUSTGI, ANIL K · 2003 to 2023
$31.7M
Training In Tumor VirologyT32CA115299 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ROBERTSON, ERLE S. · 2006 to 2021
$4.7M
Inflammation and the esophageal tumor microenvironmentU01CA143056 · NCI · UNIVERSITY OF PENNSYLVANIA · PI MAHMOOD, UMAR, RUSTGI, ANIL K · 2009 to 2013
$3.1M
PL20 AND CELL CELL ADHESIONR01CA055724 · NCI · VANDERBILT UNIVERSITY · PI REYNOLDS, ALBERT B · 1997 to 2010
$2.9M
Regulation of differentiation in esophageal epitheliaR01DK069984 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI KATZ, JONATHAN P · 2006 to 2015
$2.8M
A mouse model for p120 downregulation in cancerR01CA111947 · NCI · VANDERBILT UNIVERSITY · PI REYNOLDS, ALBERT B · 2005 to 2009
$1.7M
Regulation of p120-catenin tumor supressor activitiesR00CA138498 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI STAIRS, DOUGLAS B · 2011 to 2013
$706k
Regulation of p120-catenin tumor supressor activitiesK99CA138498 · NCI · UNIVERSITY OF PENNSYLVANIA · PI STAIRS, DOUGLAS B · 2009 to 2010
$297k
SUBSTRATES OF P60SRC PROTEIN TYROSINE KINASER29CA055724 · NCI · VANDERBILT UNIVERSITY · PI REYNOLDS, ALBERT B · 1992 to 1996
–
NCI NIH HHS 50CA95103NCI NIH HHS CA055724NCI NIH HHS CA111947NCI NIH HHS F32-CA1308513NCI NIH HHS K99 CA138498NCI NIH HHS K99/R00-CA138498NCI NIH HHS P01 CA098101NCI NIH HHS P01-CA098101NCI NIH HHS P30 CA016520NCI NIH HHS P30-CA016520NCI NIH HHS P50 CA095103NCI NIH HHS R00 CA138498NCI NIH HHS R01 CA055724NCI NIH HHS R01 CA111947NCI NIH HHS T32 CA115299NCI NIH HHS T32-CA115299NCI NIH HHS U01 CA143056NCI NIH HHS U01-CA143056NIDDK NIH HHS P30 DK050306NIDDK NIH HHS P30-DK050306NIDDK NIH HHS R01 DK069984NIDDK NIH HHS R01-DK069984
6 · The paper itself

Abstract

p120-catenin (p120ctn) interacts with E-cadherin, but to our knowledge, no formal proof that p120ctn functions as a bona fide tumor suppressor gene has emerged to date. We report herein that p120ctn loss leads to tumor development in mice. We have generated a conditional knockout model of p120ctn whereby mice develop preneoplastic and neoplastic lesions in the oral cavity, esophagus, and squamous forestomach. Tumor-derived cells secrete granulocyte macrophage colony-stimulating factor (GM-CSF), macrophage colony-stimulating factor (M-CSF), monocyte chemotactic protein-1 (MCP-1), and tumor necrosis factor-α (TNFα). The tumors contain significant desmoplasia and immune cell infiltration. Immature myeloid cells comprise a significant percentage of the immune cells present and likely participate in fostering a favorable tumor microenvironment, including the activation of fibroblasts.

Indexed as

Genes, Tumor SuppressorAnimalsCadherinsCarcinoma, Squamous CellCateninsCell DifferentiationCell Line, TumorCell ProliferationDelta CateninEsophageal NeoplasmsFibroblastsHumansInflammationMiceMouth NeoplasmsMyeloid CellsCadherinsCateninsDelta CateninNF-kappa B

Identifiers

PMID21481789
PMCPMC3077713
OpenAlexW2143726980

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.